This inventor holds 1 USPTO granted patent. Top assignees: Temple University, University of Utah Research Foundation. Active years: 2005.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2005
Title: Pedram Zendehrouh: Innovator in Antithrombin Research
Introduction
Pedram Zendehrouh is a notable inventor based in Hamden, CT (US). He has made significant contributions to the field of biochemistry, particularly in the development of modified antithrombin III compounds. His work focuses on addressing blood clotting disorders and related diseases.
Latest Patents
Zendehrouh holds a patent for "Human antithrombin IIIs and methods related thereto." This invention discloses modified antithrombin III compounds and methods that are useful in treating blood clotting disorders. The amino acid compounds developed in this patent have potential applications in various disease states associated with enzymes in the coagulation pathway.
Career Highlights
Throughout his career, Zendehrouh has worked with esteemed institutions such as the University of Utah Research Foundation and Temple University. His experience in these organizations has contributed to his expertise in the field of coagulation and enzyme research.
Collaborations
Zendehrouh has collaborated with notable colleagues, including Veronique Picard and Susan C. Bock. These partnerships have further enhanced his research and development efforts in the area of antithrombin III.
Conclusion
Pedram Zendehrouh is a distinguished inventor whose work in modified antithrombin III compounds has the potential to impact the treatment of blood clotting disorders significantly. His contributions to biochemistry and collaboration with leading researchers highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile